Crystagen

Crystagen is a synthetic linear tripeptide with the sequence Glu-Asp-Pro, abbreviated EDP, supplied as a 20 mg lyophilized vial. It belongs to the family of short peptide bioregulators developed at the St Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson, whose programme derived low-molecular-weight peptide fractions from animal tissues and then identified short synthetic sequences intended to reproduce their activity. Within that family Crystagen is catalogued as the immune-system peptide, the synthetic counterpart of the thymic preparations. Its structural relatives include Vilon, Cortagen, Cardiogen, and Bronchogen, overlapping in sequence and useful for comparative studies.

Peptide

Crystagen

Strength

20 mg

Package

20 mg

Purity

≥99%

Form

vial